Rethinking immune checkpoint blockade: ‘Beyond the T cell’

por Liu, Xiuting, Hogg, Graham D, DeNardo, David G
Publicado 2021

Phenotypic and Functional Plasticity of CXCR6(+) Peripheral Blood NK Cells

por Angelo, Laura S., Hogg, Graham D., Abeynaike, Shawn, Bimler, Lynn, Vargas-Hernandez, Alexander, Paust, Silke
Publicado 2022

Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer

por Peng, Hui, Li, Lijin, Zuo, Chong, Chen, Michael Y., Zhang, Xiuli, Myers, Nancy B., Hogg, Graham D., DeNardo, David G., Goedegebuure, S. Peter, Hawkins, William G., Gillanders, William E.
Publicado 2022

Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer

por Peng, Hui, James, C. Alston, Cullinan, Darren R., Hogg, Graham D., Mudd, Jacqueline L., Zuo, Chong, Takchi, Rony, Caldwell, Katharine E., Liu, Jingxia, DeNardo, David G., Fields, Ryan C., Gillanders, William E., Goedegebuure, S. Peter, Hawkins, William G.
Publicado 2021

Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy

por Zuo, Chong, Baer, John M., Knolhoff, Brett L., Belle, Jad I., Liu, Xiuting, Alarcon De La Lastra, Angela, Fu, Christina, Hogg, Graham D., Kingston, Natalie L., Breden, Marcus A., Dodhiawala, Paarth B., Zhou, Daniel Cui, Lander, Varintra E., James, C. Alston, Ding, Li, Lim, Kian-Huat, Fields, Ryan C., Hawkins, William G., Weber, Jason D., Zhao, Guoyan, DeNardo, David G.
Publicado 2023